EN DE
STOCK COMPARISON

Choong Ang Vaccine Laboratory Co. vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Choong Ang Vaccine Laboratory Co. (072020) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Choong Ang Vaccine Laboratory Co. as the less overvalued of the two: Choong Ang Vaccine Laboratory Co. trades at KRW 9,300 versus a fair value of KRW 7,826 (-16%), while Jiangsu Hengrui Medicine Co trades at ¥54.18 versus ¥25.94 (-52%).
Choong Ang Vaccine Laboratory Co.
072020.KQ · KRW · Energy
-16%
upside to fair value
overvalued
PriceKRW 9,300
Fair ValueKRW 7,826
Quality63/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-52%
upside to fair value
overvalued
Price¥54.18
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Choong Ang Vaccine Laboratory Co.Jiangsu Hengrui Medicine Co
Valuation
—P/E (TTM)43.6×
—P/S (TTM)10.84×
—P/B5.76×
—EV/EBITDA33.0×
—PEG0.93×
2.1%Dividend yield0.4%
KRW 200Dividend per share¥0.20
Profitability
9%Net margin25%
19%Operating margin32%
4%Return on equity15%
2%Return on assets9%
Growth
-1%Revenue growth (YoY)13%
7.7%Avg. growth/yr (3Y)13.9%
6.2%Avg. growth/yr (5Y)2.5%
Balance & size
0.05×Debt / equity—
$60MMarket cap$52B
mixedGrowth qualityhealthy

Jiangsu Hengrui Medicine Co leads: 2 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Choong Ang Vaccine Laboratory Co.of which business quality 61 · market factors 52 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 47
ProfitabilityMargins and returns on capital today
37
63
Quality GrowthAre margins and returns improving?
55
41
CashflowEarnings quality: real cash, not paper profit
35
82
Fin. StrengthBalance sheet, leverage, solvency risk
85
100
InvestmentDisciplined investing over empire-building
72
27
Low VolatilityCalm price path (market factor)
97
78
MomentumPrice trend over the last 3–12 months (market factor)
35
37
52W MomentumDistance to the 52-week high (market factor)
30
29
Net IssuanceBuybacks instead of dilution
97
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Choong Ang Vaccine Laboratory Co.

DCF ModelsKRW 6,995
Earnings-BasedKRW 5,734
MultiplesKRW 8,256
Asset-BasedKRW 7,627
Growth DCFKRW 5,298
Economic ProfitKRW 8,329
Growth EarningsKRW 8,501

20 of 24 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Choong Ang Vaccine Laboratory Co.
Bear KRW 5,752Fair Value KRW 7,826Bull KRW 9,900
KRW 9,300 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.18 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Choong Ang Vaccine Laboratory Co. · Energy

Quality score63 · Top 25%
Fair value upside-16% · above median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-52% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Choong Ang Vaccine Laboratory Co. as the less overvalued of the two: Choong Ang Vaccine Laboratory Co. trades at KRW 9,300 versus a fair value of KRW 7,826 (-16%), while Jiangsu Hengrui Medicine Co trades at ¥54.18 versus ¥25.94 (-52%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →
Choong Ang Vaccine Laboratory Co. · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Choong Ang Vaccine Laboratory Co.

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Jiangsu Hengrui Medicine Co

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.